Back | Next |
home / stock / mynz / mynz message board
Subject | By | Source | When |
---|---|---|---|
$MYNZ great article | BlazingStocks | investorshub | 04/20/2023 1:38:50 AM |
$MYNZ MomentumIts trading | budfoxfun | investorshub | 04/20/2023 1:24:10 AM |
good read | pumpnass | investorshub | 04/19/2023 8:40:01 PM |
Anyone hear anything lately? Want to see this one go | BlazingStocks | investorshub | 04/19/2023 7:56:46 PM |
The now up | Mrogers23 | investorshub | 04/19/2023 5:20:24 PM |
MomentumIts trading | BlazingStocks | investorshub | 04/19/2023 5:19:11 PM |
$MYNZ short data if anyone is interested | BooDog | investorshub | 04/19/2023 3:49:40 PM |
The now | budfoxfun | investorshub | 04/19/2023 2:01:44 PM |
The trading last up | BlazingStocks | investorshub | 04/19/2023 1:59:22 PM |
MomentumIts trading last up | BlazingStocks | investorshub | 04/19/2023 1:34:48 PM |
$MYNZ short squeeze signal | Mrogers23 | investorshub | 04/19/2023 11:31:03 AM |
bears are running | BEIJING BILL | investorshub | 04/19/2023 6:45:53 AM |
good read | budfoxfun | investorshub | 04/19/2023 5:06:21 AM |
Have a look at this | pumpnass | investorshub | 04/19/2023 3:53:49 AM |
$MYNZ MomentumIts now | BlazingStocks | investorshub | 04/19/2023 3:10:07 AM |
$MYNZ short squeeze article | budfoxfun | investorshub | 04/18/2023 12:58:41 PM |
$MYNZ MomentumIts now | BEIJING BILL | investorshub | 04/18/2023 11:35:00 AM |
$MYNZ Time for this to show some returns | BlazingStocks | investorshub | 04/18/2023 10:50:40 AM |
$MYNZ short squeeze | BlazingStocks | investorshub | 04/18/2023 6:42:09 AM |
$MYNZ The now | l2 hunter | investorshub | 04/18/2023 1:45:54 AM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Mainz BioMed CEO Guido Baechler joined Steve Darling from Proactive to announce the company has submitted an application to the U.S. Food and Drug Administration requesting Breakthrough Device Designation for its innovative non-invasive Next Generation colorectal cancer sc...
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration study ReconAAsense A recent clinical analysis of this new configuration demonstrates sens...
BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first six months ending June 30, 2024, and provided a cor...